---
figid: PMC4259948__WJCO-5-865-g001
figtitle: Schematic summary of the molecular mechanisms of HLJ1 in suppressing lung
  cancer tumourigenesis
organisms:
- NA
pmcid: PMC4259948
filename: WJCO-5-865-g001.jpg
figlink: /pmc/articles/PMC4259948/figure/F1/
number: F1
caption: 'Schematic summary of the molecular mechanisms of HLJ1 in suppressing lung
  cancer tumourigenesis. The endogenous transcriptional expression of HLJ1 is the
  result of the binding of the transcription factors AP1 and YY1 to the gene’s enhancer
  and promoter regions, respectively. HLJ1 inhibited lung cancer cell proliferation,
  anchorage-independent growth, cell motility, invasion and tumourigenesis through
  STAT1/p21WAF1 pathway, HLJ1/NPM1/AP2-α complex, SLUG/E-cadherin pathway and modulated
  cancer-related genes. DMSO: Dimethyl sulfoxide; AP1: Activating protein 1; GAS:
  Interferon-gamma activated sequence; CDKN1A: Cyclin-dependent kinase inhibitor 1A;
  YY1: Yin yang 1; STAT1: Signal transducer and activator of transcription 1; ISGF3G:
  Interferon-stimulated gene factor 3 gamma; NPM1: Nucleophosmin 1; TFAP2A: Transcription
  factor AP2 alpha; AP2: Activator protein 2; MMP2: Matrix metalloproteinase-2; SLUG:
  Snail homologue 2; CDH1: Cadherin 1; CCNG2: Cyclin G2; SERPINB1: Serine proteinase
  inhibitor B1; SESN2: Sestrin 2; TXNIP: Thioredoxin interacting protein; HMGA2: High-mobility
  group AT-hook 2; BCAT1: Branched-chain aminotransferase 1; CALD1: Caldesmon 1; E-box:
  E-box transcription factor binding site.'
papertitle: 'Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic
  target in non-small cell lung cancer.'
reftext: Meng-Feng Tsai, et al. World J Clin Oncol. 2014 Dec 10;5(5):865-873.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8843968
figid_alias: PMC4259948__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4259948__F1
ndex: ca0bd958-de9c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4259948__WJCO-5-865-g001.html
  '@type': Dataset
  description: 'Schematic summary of the molecular mechanisms of HLJ1 in suppressing
    lung cancer tumourigenesis. The endogenous transcriptional expression of HLJ1
    is the result of the binding of the transcription factors AP1 and YY1 to the gene’s
    enhancer and promoter regions, respectively. HLJ1 inhibited lung cancer cell proliferation,
    anchorage-independent growth, cell motility, invasion and tumourigenesis through
    STAT1/p21WAF1 pathway, HLJ1/NPM1/AP2-α complex, SLUG/E-cadherin pathway and modulated
    cancer-related genes. DMSO: Dimethyl sulfoxide; AP1: Activating protein 1; GAS:
    Interferon-gamma activated sequence; CDKN1A: Cyclin-dependent kinase inhibitor
    1A; YY1: Yin yang 1; STAT1: Signal transducer and activator of transcription 1;
    ISGF3G: Interferon-stimulated gene factor 3 gamma; NPM1: Nucleophosmin 1; TFAP2A:
    Transcription factor AP2 alpha; AP2: Activator protein 2; MMP2: Matrix metalloproteinase-2;
    SLUG: Snail homologue 2; CDH1: Cadherin 1; CCNG2: Cyclin G2; SERPINB1: Serine
    proteinase inhibitor B1; SESN2: Sestrin 2; TXNIP: Thioredoxin interacting protein;
    HMGA2: High-mobility group AT-hook 2; BCAT1: Branched-chain aminotransferase 1;
    CALD1: Caldesmon 1; E-box: E-box transcription factor binding site.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - YY1
  - JUND
  - FOS
  - FOSB
  - JUN
  - JUNB
  - FOSL1
  - FOSL2
  - DNAJB4
  - STAT1
  - SNAI2
  - CCNG2
  - NPM1
  - SERPINB1
  - TFAP2A
  - SESN2
  - TXNIP
  - HMGA2
  - BCAT1
  - GAST
  - GALNS
  - PAGR1
  - CD44
  - CDKN1A
  - CDPF1
  - MMP2
  - CDH1
  - FZR1
  - CALD1
  - IRF9
  - DMSO curcumin andrographolide
  - Cancer
---
